Five Star Equities Provides Stock Research on Neuralstem and Cyclacel Pharmaceuticals
Continue ReadingTag: stock-market
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on StemCells and Aastrom Biosciences
Continue ReadingSpecial Dividend Payments Increase Fourfold in 2012 as Companies Look to Avoid Upcoming Dividend Tax Increase
Five Star Equities Provides Stock Research on Health Care REIT and R.R. Donnelley & Sons
Continue ReadingEthanol Stocks Struggle as E15 Fuel Fails to Gain Widespread Adoption
The Paragon Report Provides Stock Research on Green Plains Renewable Energy and Renewable Energy Group
Continue ReadingRecent AAA Survey Shows Just 5% Cars and Trucks in the U.S. Approved to Use E15 Fuel
The Paragon Report Provides Stock Research on BioFuel Energy and Pacific Ethanol
Continue ReadingCopper Prices Soar to 6-Month Highs on Strengthening Chinese Demand
The Paragon Report Provides Stock Research on Teck Resources and Taseko Mines
Continue ReadingCopper Prices Rise as Demand From China Strengthens — Copper Demand Will Exceed Supply During First Half of 2013
The Paragon Report Provides Stock Research on Freeport-McMoRan and Southern Copper
Continue ReadingAmount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011
Five Star Equities Provides Stock Research on Ameren and Pepco Holdings
Continue ReadingThe Amount of Companies Paying Special Dividends in 2012 Is Four Times the Pace of 2011
Five Star Equities Provides Stock Research on Verizon and CenturyLink
Continue ReadingNatural Gas Heating Demand Expected to Be 34% Below Average in the Coming Weeks
The Paragon Report Provides Stock Research on EnCana and Cheniere Energy
Continue Reading